https://www.selleckchem.com/products/nlg919.html
The tapering of prednisone therapy in generalized myasthenia gravis (MG) presents a therapeutic dilemma; however, the recommended regimen has not yet been validated. To compare the efficacy of the standard slow-tapering regimen of prednisone therapy with a rapid-tapering regimen. From June 1, 2009, to July 31, 2013, a multicenter, parallel, single-blind randomized trial was conducted to compare 2 regimens of prednisone tapering. Data analysis was conducted from February 18, 2019, to January 23, 2020. A total of 2291 adults with a confirm
Gefällt mir
Kommentar
Teilen
